Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Nov 19, 2013

Mylan Announces Pricing of $2.0 Billion of Senior Notes

Nov 18, 2013

Mylan Launches First Generic Focalin XR® Capsules, 30 mg

Nov 14, 2013

Mylan Applauds New Federal Legislation to Increase Anaphylaxis Preparedness in Schools

Nov 11, 2013

Mylan Launches Generic Version of Aciphex® Tablets

Nov 06, 2013

Mylan to Present at the 2013 Credit Suisse Healthcare Conference

Nov 01, 2013

Mylan Confirms First-to-File Patent Challenge Relating to Uloric®

Oct 31, 2013

Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82

Oct 17, 2013

Mylan Appoints Jacek Glinka as President of Mylan's European Business

Oct 07, 2013

Mylan Schedules Third Quarter 2013 Financial Results Conference Call and Live Webcast

Sep 30, 2013

Mylan Launches First Generic VFEND® for Oral Suspension

Pagination

First page
Previous page
…
Page 48
Page 49
Page 50
Page 51
Current page 52
Page 53
Page 54
Page 55
Page 56
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.